Liquid biopsies that detect cancer cells or DNA in blood are improving cancer diagnostics. The human microbiome may also influence cancer immunotherapies involving gut microbes. Patient-specific testing helps researchers determine the best treatment for each individual. Single-cell profiling can provide more detailed information about tumor heterogeneity and rare cell populations. Nanotechnology is being used to more precisely deliver cancer therapies. Stakeholders are working to improve cancer care through payment reform, eliminating ineffective treatments, and helping doctors and patients avoid inappropriate care.

1. 6 APPLIED
SCIENCES
THAT WILL
TRANSFORM
CANCER
RESEARCH
Gil Schwartzberg

2. Many companies are revolutionizing
diagnostics by improving liquid
biopsies that can seek out cancer cells
or tumor DNA that are shed by tumors
in the blood.
LIQUID BIOPSY
FOR ONCOLOGY:

3. Our human microbiome is may prove
significant in the evolution of cancer
immunotherapies that utilize gut
microbes.
THE MICROBIOME

4. Patient-specific testings are aiding
researchers with anticipating proper
individual treatment reverberstion to
therapies.
PATIENT-
SPECIFIC
RESEARCH

5. Single-cell molecular profiling may
significantly impact the resolution of
intratumor heterogeneity, understand
rare tumor cell populations, measure
mutation rates, and trace cell lineage.
SINGLE- CELL
MOLECULAR
PROFILING

6. Researchers are now using
nanotechnology to carefully distribute
therapeutics to cancer cells and
strengthen the therapeutic potency of
specific treatments.
NANOTECHNOLOGY

7. Stakeholders will continue to improve
the value of cancer care by Revamping
payment structures, disposing of
inadequate therapies, and assisting
doctors as well as patients avert
improper treatment.
REEVALUATING
THE VALUE IN
CANCER
ADVANCEMENTS